Article
Europe will lose out on medical innovation if draft EU reforms pass -Novo Nordisk CEO
Rating:
0.0
Views:
66
Likes:
1
Library:
1
Europe will lose out to countries like the U.S. and Japan on new medical research, trials and treatments unless draft rules reforming the European pharmaceutical landscape change, the CEO of Danish drugmaker Novo Nordisk warned on Thursday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value